Drugs / lysate-loaded dendritic cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03879512 | Feb 2018 → Jul 2024 | glioblastoma | Wuerzburg University Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | lysate-loaded dendritic cells | “4 weekly intradermal injections of lysate-loaded dendritic cells, followed by 3 monthly boost vaccines with tumor lysate and further boost vaccines every three months” NCT03879512 ↗ |
| Modality | Vaccine | “therapeutic vaccines are increasingly used to treat HGGs” PMID 30054667 ↗ Jul 2018 |